StabilityStudy.com

Related Posts:

• The European Agency for evaluation of Medicinal Products: The European Agency for evaluation of Medicinal Products: The guideline addresses the information to be submitted in registration applications for new molecular entities and associated drug products. This guideline does not currently seek to cover the information to be submitted for abbreviated or abridged applications, variations, clinical trial applications, etc. Specific details ...
• Saudi Arabia : Guidelines for Stability Testing of New Drug Substances Saudi Arabia : Guidelines for Stability Testing of New Drug Substances and Products: The following guideline defines the stability data package for a drug substance or drug product that is sufficient for registration within the Kingdom of Saudi Arabia (K.S.A). The guideline seeks to exemplify the core stability data package for drug ...
• THE GCC GUIDELINES ON STABILITY TESTING THE GCC ( Cooperation Council for The Arab States of the Gulf ) GUIDELINES ON STABILITY TESTING OF PHARMACEUTICAL PRODUCTS : The guideline seeks to exemplify the core stability data package for drug products, but leaves sufficient flexibility to encompass the variety of different practical situations that may be encountered due to ...
• Executive – Formulation Development – Shalina Laboratories – India recognized as the No.1 pharma company in Africa, with... new products as well as existing products stability study as per ICH guideline. Go here to read the rest:  Executive - Formulation Development - Shalina Laboratories - India
• AUSTRALIAN REGULATORY GUIDELINES AUSTRALIAN REGULATORY GUIDELINES: Stability of the Finished Product Full details of stability testing conducted on the product, together with associated method validation data, must be included with the application.  ARGCM Part I, Section 6, Stability of the Finished Product sets out the requirements for stability data to support the Registration of ...